PPD clinical development and analytical services enable customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri...
Our presence in Greater China: Building a platform for market success The PPD™ clinical research business of Thermo Fisher Scientific has a team of 1,500+ professionals on the ground in China helping you navigate the complex regulatory, cultural, linguistic and logistical challenges of planning ...
Thermo Scientific Invitrogen Applied Biosystems Fisher Scientific Unity Lab Services Patheon PPD One Lambda Helping deliver life-changing therapies PPD clinical development and analytical services enable customers to accelerate innovation and increase drug development productivity. Utilizing patient-cen...
The PPD™ clinical research business of Thermo Fisher Scientific has expertise in many areas of therapeutic development services. Explore all the different disciplines of therapeutic development that we offer.
赛默飞收购PPD，又少了一个好标的，想国际化的药明康德和泰格真得想想了 EEO大健康 余诗琪/文近日，赛默飞世尔（Thermo Fisher Scientific）最终敲定收购CRO（医药研发外包）企业Pharmaceutical Product Development（以下简称“PPD”），交易金额达到174亿美元，收购溢价为24%。至此，算上2017年以72亿美元收购的CRO企业...
赛默飞世尔科技（Thermo Fisher Scientific，简称赛默飞）最终敲定以174亿美元收购合同研究机构（CRO）PPD。赛默飞最终以47.5美元/股的价格收购PPD，较周二收盘价溢价24%，并承担了PPD约35亿美元的净债务，而这不包含在174亿美元的收购额中。也就是说，这笔交易价值约209亿美元。收购PPD的交易是在赛默飞在去年最终...
EEO大健康 余诗琪/文近日,赛默飞世尔(Thermo Fisher Scientific)最终敲定收购CRO(医药研发外包)企业Pharmaceutical Product Development(以下简称“PPD”),交易金额达到174亿美元,收购溢价为24%。至此,算上2017年以72亿美元收购的CRO企业Patheon,赛默飞世尔已稳居CRO行业全球第五。
近日,赛默飞世尔(Thermo Fisher Scientific)最终敲定收购CRO(医药研发外包)企业Pharmaceutical Product Development(以下简称“PPD”),交易金额达到174亿美元,收购溢价为24%。至此,算上2017年以72亿美元收购的CRO企业Patheon,赛默飞世尔已稳...
EEO大健康 余诗琪/文近日,赛默飞世尔(Thermo Fisher Scientific)最终敲定收购CRO(医药研发外包)企业Pharmaceutical Product Development(以下简称“PPD”),交易金额达到174亿美元,收购溢价为24%。至此,算上2017年以72亿美元收购的CRO企业Patheon,赛默飞世尔已稳居CRO行业全球第五。
近日,赛默飞世尔(Thermo Fisher Scientific)最终敲定收购CRO(医药研发外包)企业Pharmaceutical Product Development(以下简称“PPD”),交易金额达到174亿美元,收购溢价为24%。至此,算上2017年以72亿美元收购的CRO企业Patheon,赛默飞世尔已稳居CRO行业全球第五。 而就在两个月前,全球第五的Icon与第六的PRA刚刚宣布合并...